B-cell tolerance checkpoint violations in systemic lupus erythematosus

Author： Kumar Kirthi Raman   Mohan Chandra  

Publisher： Future Medicine

ISSN： 1746-0816

Source： Future Rheumatology, Vol.2, Iss.4, 2007-08, pp. : 415-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B-cell-targeted therapies: promising new treatments for systemic lupus erythematosus

By Derrett-Smith Emma C   Isenberg David A  

Future Rheumatology, Vol. 3, Iss. 1, 2008-02 ,pp. : 59-68

Future Medicine

Access to resources Recommend Favorite

T-cell-directed therapy in systemic lupus erythematosus

By Hoffman Robert W  

Future Rheumatology, Vol. 1, Iss. 5, 2006-10 ,pp. : 597-605

Future Medicine

Access to resources Recommend Favorite

Malignancies in systemic lupus erythematosus

By Kale Mruganka   Ramsey-Goldman Rosalind   Gordon Caroline   Clarke Ann E   Bernatsky Sasha  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 275-280

Future Medicine

Access to resources Recommend Favorite

Cricoarytenoiditis in Systemic Lupus Erythematosus

By Nossent Johannes   Berend Kenrick  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 3, 1998-08 ,pp. : 237-238

Informa Healthcare

Access to resources Recommend Favorite

Systemic Lupus Erythematosus

By Steinsson Kristján  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 4, 1998-08 ,pp. : 318-318

Informa Healthcare

Access to resources Recommend Favorite